期刊文献+

糖尿病心肌缺血大鼠骨髓干细胞动员及心肌组织细胞因子的表达 被引量:2

Bone marrow stem cell mobilization and cytokines expression in ischemic myocardium in diabetic rats with myocardial ischemia
下载PDF
导出
摘要 目的探讨糖尿病心肌缺血大鼠外周血骨髓干细胞动员和归巢的变化以及缺血心肌组织中血管内皮生长因子和肿瘤坏死因子α的表达变化。方法首先采用链脲佐菌素腹腔注射建立雄性SD大鼠糖尿病模型,然后通过开胸结扎冠状动脉左前降支建立糖尿病心肌缺血模型,并分为缺血1d组、缺血3d组、缺血7d组、缺血28d组;另设相应时间点的糖尿病对照组(开胸但不进行动脉结扎)和正常对照组(不进行腹腔注射和动脉结扎),每组6只。应用流式细胞术测定各组大鼠的外周血单个核细胞中CD34+细胞百分率;应用免疫组化法观察各组动物缺血心肌中CD34+细胞归巢以及血管内皮生长因子和肿瘤坏死因子α的表达。结果大鼠糖尿病心肌缺血组于术后出现骨髓干细胞动员,1周内达高峰,随时间延长减弱;同时术后1周内缺血心肌组织中相应地出现骨髓干细胞归巢以及血管内皮生长因子和肿瘤坏死因子α表达明显增加。结论糖尿病缺血心肌早期可通过组织局部血管内皮生长因子和肿瘤坏死因子α表达升高而动员骨髓干细胞进入外周血,并归巢至缺血心肌,从而启动自体保护机制。 Objective To investigate the bone marrow stem cell mobilization and homing changes of peripheral blood due to diabetic myocardial ischemia in rats and the change of expression of the vascular endothelial growth factor (VEGF) and the tumor necrosis factor α (TNFα) in ischemic myocardial tissue. Methods The diabetic model of male Sprague-Dawley rats was created by intraperitoneal injection of streptozotocin first. Then the diabetic myocardial ischemia model was established through ligation of the left anterior descending coronary artery. The rats were divided into ischemic day-l, day-3, day-7, and day-28 groups. And their time-matching diabetic sham operation control group and normal sham operation control group were also established, with 6 rats in each group. Flow cytometry was used to measure the percentage of CD34+ cells in peripheral blood mononuclear cells for each group. Immunohistochemistry was used to observe the homing of CD34+ cells and the expression of VEGF and TNFα in the ischemic myocardium. Results The mobilization of bone marrow stem cells was initiated after the surgery in the rat models of myocardial ischcmia in diabetes and it peaked within 1 week and decreased with the passage of time. Accordingly the homing of CD34+ cells and the expressions of VEGF and TNFα in the ischemic myocardium were significantly increased. Conclusion During the early stage, the diabetic ischemic myocardium can mobilize bone marrow stem cells into the peripheral blood and start homing to the ischemic myocardium by increasing VEGF and TNFα in the ischemic myocardium, thereby initiating the self-protection mechanisms.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2017年第1期29-33,57,共6页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家自然科学基金资助项目(No.81200098) 陕西省自然科学基金项目(No.2014K11-03-04-06)~~
关键词 心肌缺血 糖尿病 骨髓干细胞 血管内皮生长因子 肿瘤坏死因子Α myocardial ischemia diabetes bone marrow stem cell vascular endothelial growth factor (VEGF) : tumor necrosis factor α(TNFα)
  • 相关文献

参考文献4

二级参考文献73

  • 1Sivan-Loukianova,E Awad O A,Stepanovic V, et aI.CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds.J Vasc Res.2003;40(4):368-377.
  • 2中华人民共和国国务院.医疗机构管理案例:1994-09-01.
  • 3Marcovecchio M L,Lucantoni M, Chiarelli F, et al. Role of Chronic and Acute Hyperglycemia in the Development of Diabetes Complications. Diabetes Technol Ther. 2011 ;13(3):389-392.
  • 4Rosei E A,Rizzoni D, Small artery remodelling in diabetes. J Cell Mol Med.2010;14(5): 1030-1036.
  • 5GianPaolo Fadini,Elisa Boscaro, Stefanie Dimmeler, et al.Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes.Diabetes Care.2010; 33(5):1097-1102.
  • 6Fadini GP, Agostini C, Boscaro E, et al. Mechanisms and significance of progenitor cell reduction in the metabolic syndrome Metab Syndr Relat Disord.2009;7(1 ):5-10.
  • 7Werner N, Kosiol S, Schiegl T, et al.Circulating endothelial progenitor cells and cardiovascular outcomes.N Engl J Med. 2005;353:999-1007.
  • 8Fadini GP, De Kreutzenberg SV, Coracina A, et al.Circulating CD34+ Cells, Metabolic Syndrome, and Cardiovascular Risk.Eur Heart .2006;27(18):2247-2255.
  • 9Orlandi A,Chavakis E,Seeger F, et al. Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol.2010;105(6):703-712.
  • 10Lau T, Wang D, Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine.2011 ;11 (2):189-197.

共引文献12

同被引文献28

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部